Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1993 Dec;69(6):650–654. doi: 10.1136/adc.69.6.650

Nebulised racemic adrenaline in the treatment of acute bronchiolitis in infants and toddlers.

S Kristjánsson 1, K C Lødrup Carlsen 1, G Wennergren 1, I L Strannegård 1, K H Carlsen 1
PMCID: PMC1029646  PMID: 8285776

Abstract

The effect of inhaled nebulised racemic adrenaline upon symptoms of acute bronchiolitis was investigated in 29 infants and toddlers aged 2-17.5 months by transcutaneous oxygen tension (TcPO2), oxygen saturation, transcutaneous carbon dioxide tension (TcPCO2), and clinical evaluation in a double blind placebo controlled study. Clinical score and TcPO2 improved significantly at 30, 45, and 60 minutes after inhalation of racemic adrenaline, with an increase in TcPO2 > or = 0.5 kPa in 72% of the children < 1 year of age. No significant improvement was observed after inhalation of placebo. No significant changes in heart rate or TcPCO2 were observed from before to after inhalation, but a small increase in mean systolic blood pressure was observed immediately and 45 minutes after racemic adrenaline inhalation. This study demonstrates that treatment with nebulised racemic adrenaline improved oxygenation and clinical signs in hospitalised children aged less than 18 months with bronchiolitis.

Full text

PDF
650

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bentur L., Kerem E., Canny G., Reisman J., Schuh S., Stein R., Levison H. Response of acute asthma to a beta 2 agonist in children less than two years of age. Ann Allergy. 1990 Aug;65(2):122–126. [PubMed] [Google Scholar]
  2. Carlsen K. H., Orstavik I. Bronchopulmonary obstruction in children with respiratory virus infections. Eur J Respir Dis. 1984 Feb;65(2):92–98. [PubMed] [Google Scholar]
  3. Carlsen K. H., Orstavik I., Halvorsen K. Viral infections of the respiratory tract in hospitalized children. A study from Oslo during a 90 months' period. Acta Paediatr Scand. 1983 Jan;72(1):53–58. doi: 10.1111/j.1651-2227.1983.tb09663.x. [DOI] [PubMed] [Google Scholar]
  4. Coupe M. O., Guly U., Brown E., Barnes P. J. Nebulised adrenaline in acute severe asthma: comparison with salbutamol. Eur J Respir Dis. 1987 Oct;71(4):227–232. [PubMed] [Google Scholar]
  5. Court S. D. The definition of acute respiratory illnesses in children. Postgrad Med J. 1973 Nov;49(577):771–776. doi: 10.1136/pgmj.49.577.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kjellman B., Tollig H., Wettrell G. Inhalation of racemic epinephrine in children with asthma. Dose-response relation and comparison with salbutamol. Allergy. 1980 Oct;35(7):605–610. doi: 10.1111/j.1398-9995.1980.tb01811.x. [DOI] [PubMed] [Google Scholar]
  7. Kuusela A. L., Vesikari T. A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup. Acta Paediatr Scand. 1988 Jan;77(1):99–104. doi: 10.1111/j.1651-2227.1988.tb10606.x. [DOI] [PubMed] [Google Scholar]
  8. Lenney W., Milner A. D. Alpha and beta adrenergic stimulants in bronchiolitis and wheezy bronchitis in children under 18 months of age. Arch Dis Child. 1978 Sep;53(9):707–709. doi: 10.1136/adc.53.9.707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lenney W., Milner A. D. At what age do bronchodilator drugs work? Arch Dis Child. 1978 Jul;53(7):532–535. doi: 10.1136/adc.53.7.532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lewis R. A., Austen K. F., Soberman R. J. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med. 1990 Sep 6;323(10):645–655. doi: 10.1056/NEJM199009063231006. [DOI] [PubMed] [Google Scholar]
  11. Mok J. Y., McLaughlin F. J., Pintar M., Hak H., Amaro-Galvez R., Levison H. Transcutaneous monitoring of oxygenation: what is normal? J Pediatr. 1986 Mar;108(3):365–371. doi: 10.1016/s0022-3476(86)80874-5. [DOI] [PubMed] [Google Scholar]
  12. O'Callaghan C., Milner A. D., Swarbrick A. Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants. Lancet. 1986 Dec 20;2(8521-22):1424–1425. doi: 10.1016/s0140-6736(86)92735-2. [DOI] [PubMed] [Google Scholar]
  13. Prendiville A., Rose A., Maxwell D. L., Silverman M. Hypoxaemia in wheezy infants after bronchodilator treatment. Arch Dis Child. 1987 Oct;62(10):997–1000. doi: 10.1136/adc.62.10.997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Stocks J. Recent advances in the assessment of lung function in infants. Pneumologie. 1991 Nov;45(11):881–886. [PubMed] [Google Scholar]
  15. Volovitz B., Faden H., Ogra P. L. Release of leukotriene C4 in respiratory tract during acute viral infection. J Pediatr. 1988 Feb;112(2):218–222. doi: 10.1016/s0022-3476(88)80058-1. [DOI] [PubMed] [Google Scholar]
  16. Volovitz B., Welliver R. C., De Castro G., Krystofik D. A., Ogra P. L. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res. 1988 Oct;24(4):504–507. doi: 10.1203/00006450-198810000-00018. [DOI] [PubMed] [Google Scholar]
  17. Wang E. E., Milner R., Allen U., Maj H. Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial. Arch Dis Child. 1992 Mar;67(3):289–293. doi: 10.1136/adc.67.3.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wennergren G., Engström I., Bjure J. Transcutaneous oxygen and carbon dioxide levels and a clinical symptom scale for monitoring the acute asthmatic state in infants and young children. Acta Paediatr Scand. 1986 May;75(3):465–469. doi: 10.1111/j.1651-2227.1986.tb10231.x. [DOI] [PubMed] [Google Scholar]
  19. Wennergren G., Kristjánsson S., Sten G., Bjure J., Engström I. Nebulized racemic adrenaline for wheezy bronchitis. Acta Paediatr Scand. 1991 Mar;80(3):375–377. doi: 10.1111/j.1651-2227.1991.tb11865.x. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES